SAB Biotherapeutics

Price & Volume

Stats

Open	$3.79
Previous Close	$3.85
Day Range	$3.77-$3.80
52W Range	$1-$5.15
Market Cap	$270.5M
Shares Short	1M

Financials

Revenue (12 Mos)	$114,698
Revenue Growth (YoY)	-62.4%
Gross Profit (12 Mos)	-$33.3M
Diluted EPS	-$0.79

News

Yahoo Finance • 13 days ago

SAB Biotherapeutics slips 5%, prices $85M stock offering

Yahoo Finance • 21 days ago

SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes

Yahoo Finance • 3 months ago

SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D

Yahoo Finance • 4 months ago

SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management

About

CEO	Mr. Samuel J. Reich
CFO	Ms. Lucy To
Address	777 W 41st St., Miami Beach, FL, United States, 33140
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	86